Haemonetics (HAE) Non-Current Assets (2010 - 2026)

Haemonetics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• In Q1 2026, Non-Current Assets rose 2.97% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $6.2 billion (changed 0.43% YoY), while the FY2026 annual figure was $1.6 billion, up 2.97% from the prior year.
• Non-Current Assets was $1.6 billion for Q1 2026 at Haemonetics, up from $1.5 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.6 billion in Q3 2024 to a low of $1.1 billion in Q1 2022.
• Historically, Non-Current Assets has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2023.
• Biggest YoY gain for Non-Current Assets was 69.6% in 2022; the steepest drop was 2.01% in 2022.
• A 5-year view of Non-Current Assets shows it stood at $1.2 billion in 2022, then advanced by 22.5% to $1.4 billion in 2023, then increased by 6.27% to $1.5 billion in 2024, then increased by 1.43% to $1.5 billion in 2025, then grew by 0.89% to $1.6 billion in 2026.
• The last three Non-Current Assets figures came in at $1.6 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.